Literature DB >> 8759950

The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements.

M P Gorga1, L Stover, S T Neely, D Montoya.   

Abstract

Distortion product otoacoustic emission (DPOAE) input/output functions were measured at nine f2 frequencies ranging from 500 to 8000 Hz in 210 normal-hearing and hearing-impaired subjects. In a companion paper [Stover et al., J. Acoust. Soc. Am. 100, 956-967 (1996)], L1-L2 was held constant at 10 dB, and L2 was varied from 65 to 10 dB SPL in 5-dB steps. Based upon analyses using clinical decision theory, it was demonstrated that DPOAE amplitudes for 65/55 dB SPL primaries (L1/L2) and DPOAE thresholds resulted in the greatest separation between normal and impaired ears. In this paper, the data for these two conditions were recast as cumulative distributions, which not only describe the extent of overlap between normal and impaired distributions, but also provide the measured value (i.e., the specific DPOAE amplitude or threshold) for any combination of hit and false alarm rates. From these distributions, confidence limits were constructed for both DPOAE amplitude and threshold to determine the degree of certainty with which any measured response could be assigned to either the normal or impaired population. For these analyses, DPOAE measurements were divided into three categories (a) response properties that would be unlikely to come from normal ears, (b) response properties that would be unlikely to come from impaired ears, and (c) response properties for which hearing status was uncertain. Based upon DPOAE amplitude measurements, the region of uncertainty, defined between the 95 percentile for impaired ears and the 5 percentile for normal ears, was relatively narrow for f2 frequencies ranging from 707 to 4000 Hz. For DPOAE thresholds, this region was relatively narrow for F2 frequencies ranging from 1414 to 4000 Hz.

Entities:  

Mesh:

Year:  1996        PMID: 8759950     DOI: 10.1121/1.416208

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  12 in total

1.  A validation and potential clinical application of multivariate analyses of distortion-product otoacoustic emission data.

Authors:  Michael P Gorga; Darcia M Dierking; Tiffany A Johnson; Kathryn L Beauchaine; Cassie A Garner; Stephen T Neely
Journal:  Ear Hear       Date:  2005-12       Impact factor: 3.570

2.  Distortion product otoacoustic emissions: cochlear-source contributions and clinical test performance.

Authors:  Tiffany A Johnson; Stephen T Neely; Judy G Kopun; Darcia M Dierking; Hongyang Tan; Connie Converse; Elizabeth Kennedy; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2007-12       Impact factor: 1.840

3.  Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.

Authors:  Angela C Garinis; Douglas H Keefe; Lisa L Hunter; Denis F Fitzpatrick; Daniel B Putterman; Garnett P McMillan; Jeffrey A Gold; M Patrick Feeney
Journal:  Ear Hear       Date:  2018 Jan/Feb       Impact factor: 3.570

4.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

5.  Multivariate DPOAE metrics for identifying changes in hearing: perspectives from ototoxicity monitoring.

Authors:  Dawn Konrad-Martin; Kelly M Reavis; Garnett P McMillan; Marilyn F Dille
Journal:  Int J Audiol       Date:  2012-02       Impact factor: 2.117

6.  Longitudinal Development of Distortion Product Otoacoustic Emissions in Infants With Normal Hearing.

Authors:  Lisa L Hunter; Chelsea M Blankenship; Douglas H Keefe; M Patrick Feeney; David K Brown; Annie McCune; Denis F Fitzpatrick; Li Lin
Journal:  Ear Hear       Date:  2018 Sep/Oct       Impact factor: 3.570

7.  Audiometric predictions using stimulus-frequency otoacoustic emissions and middle ear measurements.

Authors:  John C Ellison; Douglas H Keefe
Journal:  Ear Hear       Date:  2005-10       Impact factor: 3.570

8.  Otoacoustic emission responses of the cochlea to acute and total ischemia.

Authors:  Yavuz Selim Yıldırım; Fadlullah Aksoy; Orhan Ozturan; Bayram Veyseller; Hasan Demirhan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-08-28

9.  Using benefit-cost ratio to select Universal Newborn Hearing Screening test criteria.

Authors:  Heather L Porter; Stephen T Neely; Michael P Gorga
Journal:  Ear Hear       Date:  2009-08       Impact factor: 3.570

10.  Distortion-product otoacoustic emission input/output characteristics in normal-hearing and hearing-impaired human ears.

Authors:  Stephen T Neely; Tiffany A Johnson; Judy Kopun; Darcia M Dierking; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2009-08       Impact factor: 1.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.